Biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of its shares on Nasdaq First North.
Guard Therapeutics, a Swedish biotech company, has received conditional approval from Nasdaq Stockholm. The approval concerns continued listing of the company's shares on Nasdaq First North.
The decision was announced on July 16, 2026. It allows the company to remain on the marketplace under certain conditions.
AIによるレポート AIによって生成された画像
The German-French defense company KNDS has postponed its planned stock market listing in Paris and Frankfurt. The firm wants to wait for better market conditions. The German government is sticking to its planned entry nonetheless.
Medical technology company SpectraCure in Lund is carrying out a rights issue that will add 34.2 million kronor if fully subscribed. The issue will finance clinical studies and regulatory applications. The share fell more than 20 percent on Monday.
AIによるレポート
Enhanced Group Inc. started trading on the NYSE in early May following its combination with Paradise Acquisition Corp. The telehealth firm focuses on peptides and performance-enhancing products.
Biotech company Carbiotix in Lund has been declared bankrupt. The firm was delisted from Spotlight Stock Market at the end of last year.
AIによるレポート
ARS Pharmaceuticals held its first quarter 2026 earnings conference call on May 15, highlighting early momentum in the new year. Company executives emphasized growth drivers including expanded access for its neffy product. The call featured forward-looking statements about the firm's commercial progress.
Danish drugmaker Novo Nordisk is taking a local compounding pharmacy to court in Pretoria to stop the sale of unregistered semaglutide products. The High Court application targets iDexis over patient safety concerns.
AIによるレポート
The Egyptian government has confirmed plans to list four Armed Forces-affiliated companies on the Egyptian Exchange during a Wednesday meeting chaired by Prime Minister Mostafa Madbouly.